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Abstract: Mannosidases catalyze the hydrolysis of a diverse
range of polysaccharides and glycoconjugates, and the various
sequence-based mannosidase families have evolved ingenious
strategies to overcome the stereoelectronic challenges of
mannoside chemistry. Using a combination of computational
chemistry, inhibitor design and synthesis, and X-ray crystal-
lography of inhibitor/enzyme complexes, it is demonstrated
that mannoimidazole-type inhibitors are energetically poised
to report faithfully on mannosidase transition-state conforma-
tion, and provide direct evidence for the conformational
itinerary used by diverse mannosidases, including b-manna-
nases from families GH26 and GH113. Isofagomine-type
inhibitors are poor mimics of transition-state conformation,
owing to the high energy barriers that must be crossed to attain
mechanistically relevant conformations, however, these sugar-
shaped heterocycles allow the acquisition of ternary complexes
that span the active site, thus providing valuable insight into
active-site residues involved in substrate recognition.
Mannosidases are glycoside hydrolases (GHs) which cata-
lyze the cleavage of glycosidic linkages in mannose-contain-
ing glycoconjugates and polysaccharides. a-Mannosidases are
important in N-glycan biosynthesis and protein quality
control and their inhibition may allow intervention in diseases
which utilize N-linked glycans for protein folding.[1] b-
Mannosidases are important in the degradation of plant-
derived mannans (b-mannan, glucomannan, galactomannan)
and are of industrial significance in the detergent, food,
biofuels, and oil and gas industries.[2] Biochemical studies of
mannosidases from different sequence-based families have
highlighted that a variety of conformational itineraries,[3] and
a range of mechanistic strategies are employed for glycosidic
bond cleavage.[4] The study of the diverse pathways employed
by mannosidases can inform synthetic efforts designed to
overcome the often recalcitrant chemistry of mannose.[5]
A rationalization of the rate enhancement achieved by an
enzyme pivots upon an understanding of its transition state.
This understanding in turn can instruct the development of
transition-state analogue inhibitors, which have exciting
potential as drug candidates.[6] Mannosidase inhibitors are
designed to mimic the charge, planarity, and conformation of
the oxocarbenium ion-like “exploded” transition state(s) of
mannosidase-catalyzed hydrolysis. Upon protonation, isofa-
gomine-type inhibitors, exemplified by isofagomine (IFG)
1 (Figure 1), resemble a glycosyl cation with charge localized
at C1, but are poor mimics of transition-state conformation.
Figure 1. Structures of isofagomine (1), mannoimidazole (2), ManIFG
(3), and ManMIm (4).
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Alternatively, mannoimidazole
(MIm)-type inhibitors, for example,
2, are qualitatively good models of
a mannopyranosyl oxocarbenium ion-
like transition state, with
sp2 hybridization of equivalent atoms
and the potential for anti protona-
tion[7] of the imidazole functionality.
Structural studies aimed at identify-
ing the conformation of the transition
state and flanking ground states on
the reaction coordinate, utilizing 2,
and related inhibitors as transition-
state and ground-state mimics, iden-
tified a 1S5$B2,5$OS2 conforma-
tional itinerary for mannosidases of
families GH2,[8] 38,[9] and 92,[10] and
a 3S1!3H4!1C4 itinerary for the a-
mannosidases of GH47.[11] However,
it is now apparent that complexes
with 2 can report on both the tran-
sition-state conformation and confor-
mational itinerary.[11] Quantitative
kinetic and thermodynamic analyses
using Bartlett plots and isothermal
titration calorimetry suggest 2 is
a true transition-state mimic.[8,11]
However, these energetic analyses
do not report which features of the
ligand imbue transition-state mimi-
cry.
Herein we present syntheses of
new b-mannanase-targeted inhibitors,
ManIFG (3) and ManMIm (4 ; Figure 1). Together with 1,4-b-
mannobiose, 3 afforded a unique ternary complex with the b-
mannanase of family GH113, thus defining the active-site
cleft. Compound 4 was used to obtain new transition-state
mimicking complexes with b-mannanases of families GH26
and GH113, thus allowing the assignment of conformational
itineraries for these enzymes. The conformations of the
inhibitors in these novel structures and previously reported
mannosidase complexes of these classes of inhibitors were
correlated with quantummechanical (QM) calculations of the
free-energy landscape (FEL) for 1 and 2 “off-enzyme”, to
identify which conformations better resemble the mannosi-
dase transition state.
A 1S5!B2,5!OS2 glycosylation conformational itinerary
has been proposed for GH26 mannanases on the basis of the
transition-state flanking Michaelis complex in a 1S5 confor-
mation,[12] and the glycosyl–enzyme intermediate in an OS2
conformation,[13] combined with the principle of least nuclear
motion. Only the uncomplexed form of a sole GH113 b-
mannanase has been solved and no proposals have been
advanced for transition-state conformation for this family.[14]
To gain direct evidence for transition-state conformation for
these two families, the isofagomine and mannoimidazole
inhibitor “warheads” were used to develop new inhibitors
targeted at the representative b-mannanases from families
GH26 and GH113, b-1,4-mannobiohydrolase from Cellvibrio
japonicus CjMan26C, and endo-b-1,4-mannanase from Alicy-
clobacillus acidocaldarius AaManA, respectively. The syn-
thesis of 3 and 4 is outlined in Scheme 1 (see the Supporting
Information).
Compounds 3 and 4 are potent inhibitors of CjMan26C
with KI values of (263 15) and (194 8) nm, respectively,
thus partly reflecting an unusually high-affinity 2 subsite.[15]
Soaking 3 and 4 into crystals of CjMan26C yielded complexes
that diffracted to a resolution of 1.2 and 1.1 , respectively,
with inhibitors occupying the 2 and 1 subsites (Figure 2a;
see Figures S1a, S2; Table S1 in the Supporting Information).
The MIm moiety in the 1 subsite of the CjMan26C/4
complex adopts a B2,5 conformation, which is consistent with
the proposed 1S5!B2,5!OS2 glycosylation conformational
itinerary for GH26.
Compounds 3 and 4 are weaker inhibitors of AaManA
withKI values of (0.26 0.04) and 1.3 mm, respectively, which
are consistent with this enzyme exhibiting a preference for
binding elongated substrates in the  and + subsites distal to
2 and 1. Soaking 4 into crystals of AaManA yielded
a complex that diffracted to a resolution of 1.5  with the
ligand occupying the 2 and 1 subsites. The MIm moiety in
the 1 subsite adopts a B2,5 conformation (Figure 2b; see
Figure S2 and Table S1). By invoking the principle of least
nuclear motion, this complex is diagnostic of a 1S5!B2,5!OS2
conformational itinerary for family GH113. Soaking 3, either
Scheme 1. a) 4-Toluoyl chloride, DMAP, pyridine, CH2Cl2, 88%; b) TFA, Et3SiH, CH2Cl2, 93%; c) 16,
Tf2O, 2,4,6-tri-tert-butylpyrimidine, 60%; d) 1. NaOMe, 2. H2, Pd(OH)2, AcOH/H2O/THF, 80%;
e) PMBCl, NaH, DMF,78%, f) 1. H2O, NIS, acetone, 0 8C, 78%, 2. DMSO, Ac2O; g) 1. NH3, Et2O,
reflux; 2. DMSO, Ac2O, 3. HCO2H, NaBH3(CN), MeCN, 74% over 4 steps; h) Lawesson’s reagent,
pyridine, toluene, 99%; i) H2NCH2CH(OMe)2; j) TsOH, toluene, H2O, 50 8C, 65% over 2 steps;
k) TfOH, NIS, CH2Cl2, 0 8C, 39%; l) H2 (6 bar), Pd(OH)2, AcOH/EtOAc/MeOH/H2O, 58%.
DMAP=4-(N,N-dimethylamino)pyridine, DMF=N,N-dimethylformamide, DMSO=dimethylsulfox-
ide, NIS=N-iodosuccinimide, PMB=para-methoxybenzyl, TFA= trifluoroacetic acid, Tf= trifluoro-
methanesulfonyl, THF= tetrahydrofuran, Ts=4-toluenesulfonyl.
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alone, or with 1,4-b-mannobiose, into crystals of AaManA
yielded binary and ternary complexes which diffracted to
a resolution of 1.6  (Figure 2c; see Figures S1b and S2, and
Table S1). The ternary complex with 3 bound in the 2 and
1 subsites, and 1,4-b-mannobiose bound in the +1 and +2
subsites, provides the first complete mapping of substrate-
binding amino acid residues across the 2 to +2 subsites for
a GH113 enzyme (Figure 2c; see Figure S2 and Table S1).
To understand the intrinsic conformational preferences of
1[16] and 2, we employed QM calculations to construct
a conformational FEL. The FEL of 1 reveals that the 4C1
conformation is preferred, with the mechanistically relevant
1C4 andB2,5 conformations located 5 and 8 kcalmol
1 higher in
energy, respectively, and with a greater than 10 kcalmol1
barrier for their interconversion (Figure 3a). These data
suggest that IFG is a poor transition-state mimic and
consistent with this the 4C1 conformation is the only con-
formation observed for isofagomine-type inhibitors when
bound to mannosidases (Figure 3a). Other conformations
have been observed for isofagomine-type inhibitors bound to
glucosidases/cellulases (see Figure S3). In striking contrast,
the FEL of 2 is consistent with good transition-state shape
mimicry, with all mechanistically relevant half-chair (4H3 and
3H4), envelope (
3E, E3,
4E, and E4), and boat (
2,5B or B2,5)
conformations energetically accessible (Figure 3b). A global
minimum was found near the 4H3 conformation with a second
local minimum approximately 1 kcalmol1 higher in energy
near the 3H4 conformation, both of which have been observed
on-enzyme. The other conformation of 2, which has been
observed on-enzyme, the B2,5, was near a saddle point
between these local minima and was 5 kcalmol1 higher in
energy than the 3H4 conformation. The FEL for 2 reveals that
the conformations relevant to the reaction coordinate are all
energetically accessible, and moreover, that a B2,5 conforma-
tion is less stable than theE andH conformations. This in turn
suggests that the observation of a B2,5 conformation for 2 on-
enzyme is of special mechanistic significance, with the enzyme
inducing the inhibitor to adopt a conformation to match the
transition state.
Collectively, the conformations of mannoimidazole-type
inhibitors bound to mannosidases of diverse families high-
lights that mannosidases readily modulate the ligand con-
formational landscape. This conclusion is consistent with FEL
Figure 2. a) Binary complex of ManMIm (4) bound to CjMan26C.
b) Binary complex of 4 bound to AaManA. c) Ternary complex showing
ligand binding within the active site of GH113 b-mannanase AaManA.
ManIFG (3) occupies the 2 and 1 subsites, whilst b-1,4-manno-
biose is observed within +1 and +2 subsites. Depicted electron
density maps are REFMAC maximum-likelihood/sA-weighted 2FoFc
syntheses contoured at 0.41, 0.38, and 0.41 electrons per 3, respec-
tively.
Figure 3. Conformational free-energy landscapes (FELs, Mercator projec-
tion) of isolated isofagomine (1; a) and protonated mannoimidazole (2 ;
b), contoured at 1 kcalmol1. FELs have been annotated with the
conformations of isofagomine-type (for a) and mannoimidazole-type (for
b) inhibitors which have been observed on-enzyme. a) 1: 3 bound to
GH26 CjMan26C (this work); 2: 3 bound to GH113 AaManA (this work);
3: a-Glc-1,3-isofagomine bound to BxGH99 (PDB code 4AD2).[17] b) 1: 4
bound to GH26 CjMan26C (this work); 2: 4 bound to GH113 AaManA
(this work); 3: 1 bound to GH2 BtMan2A (PDB code 2VMF);[18] 4:
1 bound to GH47 CkMan47 (PDB code 4AYP);[11] 5: 1 bound to GH38
DmGManII (PDB code 3D4Y) in half-chair conformer;[19] 6: 1 bound to
GH38 DmGManII (PDB code 3D4Y) in boat conformer (this work); 7:
1 bound to GH92 BtMan3990 (PDB code 2WZS).[20]
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analysis of a-d-mannopyranose bound to a GH47 a-manno-
sidase, and established that the enzyme reshapes the con-
formational landscape, thus defining the energetically acces-
sible space.[11] For enzymes from GH2,[21] GH26,[13] and
GH47,[11] conformations of ground states adjacent to the
transition state (Michaelis, glycosyl-enzyme or product com-
plexes) provide strong evidence that mannoimidazole-type
inhibitors authentically report transition-state conformation
on-enzyme. However, the 4H3 conformation reported for the
complex of 2 and Drosophila melanogaster Golgi GH38 a-
mannosidase II (DmGManII) is inconsistent with this inter-
pretation.[19] On the basis of a glycosyl–enzyme intermediate
in a 1S5 conformation,
[9] and theory,[22] a B2,5 transition-state
conformation is predicted. Inspection of the density map
reveals significant residual electron density in the complex,[23]
and re-refinement of these data with 2 in two conformations
shows that 30–40% of the ligand binds as a second transition-
state mimicking conformer in an approximate B2,5 conforma-
tion (see Figure S4).
We next analyzed the atomic charges and ring planarity of
the four mechanistically relevant conformations (4H3,
3H4,
B2,5,
2,5B) of 2. We combined the values of the charge
development at the C1 atom (qC1), the C5-O5-C1-C2 dihedral
angle, and the free energy for a large set of representative
structures into a unique index (named “TS index”, TSi, see
the Supporting Information), in the spirit of the previously
reported preactivation index for isolated aldohexoses.[11,24]
Table S2 and Figures S5 and S6 show that there is no single
conformation with the optimum values for every parameter
(score= 100). The TSi values (see Figure S7) reveal that even
though the H conformations are favored over B conforma-
tions when solely considering their energy (Figure 2b), they
possess different TSi values. Most importantly, the two
transition-state mimicking conformations that have been
observed on-enzyme, 3H4 and B2,5, have the highest TSi val-
ues. Therefore, as observed for glycans bound to GHs,[3,25] the
inhibitor conformation on-enzyme is not only dictated by the
relative energy of the molecule itself but also by structural
and electronic properties.
In conclusion, the calculated FEL of 2 shows a preference
for 3H4 and
4H3 half-chair conformations, and that a B2,5
conformation represents a higher energy, but easily accessible
saddle point between these two minima and thus that
mannoimidazole-type inhibitors, in contrast to the isofago-
mine-type, are energetically poised to faithfully report
transition-state conformation. X-ray structures of 4 with two
b-mannanases from GH26 and GH113 provide the first direct
evidence for a B2,5 conformation of the transition state of the
enzyme-catalyzed reaction of these families. Previous work
with GH47 a-mannosidases found that 2 bound in a 3H4
conformation, implicating a 3S1!3H4!1C4 itinerary for this
family (Figure 4a). The B2,5 conformation has now been
observed for mannoimidazole-type inhibitors in complex with
a- and b-mannosidases from five GH families: GH2, 26, 38,
92, and 113 (Figure 4b). A 1S5$B2,5$OS2 conformational
itinerary is common to all of these families, a result that
unifies mannosidases which operate through both retaining
and inverting, and metal-dependent and metal-independent
mechanisms.
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